Sincalide
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
25126-32-3CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=OIZTQOLKUZKXIRV-YRVFCXMDSA-NSincalide is an oligopeptide.
25126-32-3DTXSID7048617CHEMBL1121Breast Feeding; Lactation; Milk, Human; Gastrointestinal Hormones; Cholecystokinin; Diagnostic Agents
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Drug Induced Liver Injury Rank (DILIrank 2.0)
Sincalide
vNo-DILI-concern
0
No match
DOI:10.1016/j.drudis.2016.02.015
V - Various
QV - Various
Following an intravenous (bolus) injection of 0.02 mcg/kg of sincalide, maximal contraction of the gallbladder occurred in 5 to 15 minutes. Sincalide reduced gallbladder radiographic size by at least 40%, generally considered satisfactory contraction.
When injected intravenously, sincalide produces a substantial reduction in gallbladder size by causing this organ to contract. The evacuation of bile that results is similar to that which occurs physiologically in response to endogenous cholecystokinin. Like cholecystokinin, sincalide stimulates pancreatic secretion; concurrent administration with secretin increases both the volume of pancreatic secretion and the output of bicarbonate and protein (enzymes) by the gland. This combined effect of secretin and sincalide permits the assessment of specific pancreatic function through measurement and analysis of the duodenal aspirate.
M03GIQ7Z6P
SINCALIDE
Chemical Structure [CS] - Cholecystokinin
Established Pharmacologic Class [EPC] - Cholecystokinin Analog
Sincalide is a Cholecystokinin Analog.
SINCALIDE
The intravenous (bolus) administration of sincalide causes a prompt contraction of the gallbladder that becomes maximal in 5 to 15 minutes, as compared with the stimulus of a fatty meal which causes a progressive contraction that becomes maximal after approximately 40 minutes.
CHEBI:135946Limited information is available on the route of elimination of sincalide
Limited information is available on the volume of distribution of sincalide.
VerwendenSincalide is used in the biological studies in the preparation of opioid receptors agonistic and CCK receptor antagonistic activity.